Assorted News from the Last Week: CAC2 Student Member and Rookie-of-the Year Joshua Omale published on the global rise in young-onset cancers and the role
By CAC2 Staffer Bethany Lieberman School-aged children typically embrace the summer season with a sense of joy and abandon. For me, it’s usually a time
Assorted News from the Last Week: CAC2 Supporting Organization Jazz Pharmaceuticals announced that the FDA granted accelerated approval for Modeyso™ (dordaviprone) for the treatment of
Assorted News from the Last Week: Scoping review of the utilization of wearable devices in pediatric and young adult oncology Engineered L-asparaginase variants with enhanced
Assorted News from the Last Week: Researchers at the University of Florida are moving closer to developing what they have described as a “universal” cancer
Assorted News from the Last Week: Muscle weakness in cancer survivors may be caused by treatable weakness in blood vessels. An aggressive childhood cancer case
Assorted News from the Last Week: Survival rates for cancer patients on immunotherapy depend on insurance coverage: Those on private insurance or Medicaid had higher survival
Assorted News from the Last Week: CAC2 Guest Blog Post–The National Cancer Institute (NCI) will host the CCDI Symposium this October and bring together the
The National Cancer Institute (NCI) will host the CCDI Symposium this October and bring together the childhood cancer community to learn about CCDI programs and
Assorted News from the Last Week: Nutritional status, body composition, and chemotherapy dosing in children and young people with cancer: a systematic review by the
